Skip to main content
Clinical Trials/NCT05662163
NCT05662163
Not Yet Recruiting
N/A

Effect of General Anesthesia Method Chosen in Non-cardiac Surgery of Cardiac Risk Patients on Ischemia Modified Albumin and Heart-Type Fatty Acid-Binding Protein (H-FABP) Levels

Ataturk University0 sites70 target enrollmentDecember 30, 2022
ConditionsAnesthesia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anesthesia
Sponsor
Ataturk University
Enrollment
70
Primary Endpoint
comparing serum levels of heart fatty acid binding protein
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

To examine the effects of the general anesthesia method chosen in non-cardiac surgical operations of patients with cardiac risk on the levels of cardiac markers

Detailed Description

To examine the effects of the general anesthesia method chosen in non-cardiac surgical operations of patients with cardiac risk on the levels of cardiac markers like; serum levels of the Creatine Kinase, Creatine Kinase Myocardial Band, high sensitive troponin, heart-type fatty acid-binding protein, ischemia-modified albumin and albumin. And evaluate the effect of anesthesia method on haemodynamic.

Registry
clinicaltrials.gov
Start Date
December 30, 2022
End Date
December 30, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Aysenur Dostbil

Clinical Professor

Ataturk University

Eligibility Criteria

Inclusion Criteria

  • Being 18 years or older
  • Getting a score of 2 and above according to the Lee cardiac index
  • Having a non-cardiac surgical procedure that will take at least three hours
  • ASA II or III

Exclusion Criteria

  • Under 18 years old
  • Those who refused to participate in the study
  • Patients with chronic renal failure
  • Patients with creatinine value ≥ 1.5 mg/dl
  • Surgery that takes less than 3 hours
  • Patients with liver failure
  • Refusing to participate in the study
  • Being allergic to the drugs used

Outcomes

Primary Outcomes

comparing serum levels of heart fatty acid binding protein

Time Frame: intraoperative period

serum levels of heart fatty acid binding protein (in terms of mcg/L)

comparing serum levels of ischemia modified albumin

Time Frame: intraoperative period

serum levels of ischemia modified albumin (in terms of IU/ML)

Secondary Outcomes

  • The effect of anesthesia method used in cardiac risk patients in terms of ephedrine consumption(intraoperative period)

Similar Trials